Prominent healthcare-focused US venture capital firm RA Capital has expanded its China footprint with a new Shanghai office, aiming to tap innovation in the Chinese biotech ecosystem as US firms navigate Washington’s escalating scrutiny of cross-border deals. Boston-headquartered RA Capital now has 12 China-based staff members, including four investment professionals who started working in the country in the past few months, partner Josh Resnick said in an interview on Wednesday. The firm’s new...
Read full article